Indazole

Indazole

SCHEMBL492915

NC1CN2CCC1CC2.c1ccc2[nH]ncc2c1

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.53
IDO1 P14902 1/20 0.53
CDK2 P24941 1/20 0.53
ABCB1 P08183 1/20 0.47
CHRNA7 P36544 2/20 0.47
HTR3A P46098 1/20 0.40
ROCK2 O75116 10/20 0.39
ROCK1 Q13464 8/20 0.39
CCR2 P41597 5/20 0.39
CYP3A4 P08684 1/20 0.38
ALDH1A1 P00352 1/20 0.37
PARP1 P09874 1/20 0.37
PRKCI P41743 1/20 0.37
PDE4B Q07343 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
ARHGDIA P52565 1/20 0.37
CDC7 O00311 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Indazole SCHEMBL27558509 0.73 HSP90AA1 (0.91) HSP90AA1IDO1CDK2ABCB1ROCK2
Indazole SCHEMBL6295 0.73
Indazole SCHEMBL29355507 0.73
Indazole SCHEMBL1221882 0.73 HSP90AA1 (1.00) HSP90AA1IDO1CDK2ABCB1ROCK2
SCHEMBL492755 0.72 CHRNA7 (0.47) CHRNA7HTR3A
Indazole SCHEMBL27982546 0.71 HSP90AA1 (0.86) HSP90AA1IDO1CDK2ABCB1ROCK2
Indazole SCHEMBL27326012 0.71 HSP90AA1 (0.86) HSP90AA1IDO1CDK2ABCB1ROCK2
Indazole SCHEMBL28096749 0.71 HSP90AA1 (0.86) HSP90AA1IDO1CDK2ABCB1ROCK2
Indazole SCHEMBL5221603 0.71 HSP90AA1 (0.95) HSP90AA1IDO1CDK2ABCB1ROCK2
Indazole SCHEMBL110751 0.71 HSP90AA1 (0.95) HSP90AA1IDO1CDK2ABCB1ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8273891-B2 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof MEMORY PHARMACEUTICALS CORPORATION (US) 2012-09-25 US disclosed
US-8106066-B2 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof MEMORY PHARMACEUTICALS CORPORATION (US) 2012-01-31 US disclosed
US-20100137288-A1 INDAZOLES, BENZOTHIAZOLES, BENZOISOTHIAZOLES, BENZISOXAZOLES, PYRAZOLOPYRIDINES, ISOTHIAZOLOPYRIDINES, AND PREPARATION AND USES THEREOF SCHUMACHER RICHARD 2010-06-03 US disclosed
EP-1940833-A1 INDAZOLES, BENZOTHIAZOLES, BENZOISOTHIAZOLES, BENZISOXAZOLES, PYRAZOLOPYRIDINES, ISOTHIAZOLOPYRIDINES, AND PREPARATION AND USES THEREOF Memory Pharmaceuticals Corporation (US) 2008-07-09 EP disclosed
US-20070078147-A1 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof MEMORY PHARMACEUTICALS CORPORATION 2007-04-05 US disclosed
WO-2007038367-A1 INDAZOLES, BENZOTHIAZOLES, BENZOISOTHIAZOLES, BENZISOXAZOLES, PYRAZOLOPYRIDINES, ISOTHIAZOLOPYRIDINES, AND PREPARATION AND USES THEREOF MEMORY PHARMACEUTICALS CORPORATION (US) 2007-04-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137288-A1 INDAZOLES, BENZOTHIAZOLES, BENZOISOTHIAZOLES, BENZISOXAZOLES, PYRAZOLOPYRIDINES, ISOTHIAZOLOPYRIDINES, AND PREPARATION AND USES THEREOF CHRNA7, CHRNA5, CHRNA2 HSP90AA1 3352/4885IDO1 1579/4885CDK2 3337/4885
US-20070078147-A1 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof CHRNA7, CHRNA5, CHRNA2 HSP90AA1 3352/4885IDO1 1579/4885CDK2 3337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.